SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote ()3/8/2000 6:16:00 PM
From: Ron   of 1386
 
I have a question: With all the news already out, what is the chance that PARS will receive a partner for final stage HU-211? PARS insists on trying it alone, but I think that is dangerous as earnings are not rising as expected, at least not what this thread was expecting. And I wonder whether the results just released for HU-211 will attract new money. The results were not overwhelming. IMO, we need a very reputable "person" or "newsprint" to echo the positives of phase2/3 for Hu-211 before a price increase.
Goodluck to us longs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext